253 related articles for article (PubMed ID: 32170578)
1. Pembrolizumab-associated nephrotic syndrome recovered from transient hemodialysis in a patient with lung cancer.
Ishibuchi K; Iwakura T; Kaneko M; Fukasawa H; Furuya R
CEN Case Rep; 2020 Aug; 9(3):215-219. PubMed ID: 32170578
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab.
Taki T; Oda N; Fujioka Y; Mitani R; Tokura T; Takata I; Oshiro Y; Takigawa N
Intern Med; 2020 Jul; 59(13):1639-1642. PubMed ID: 32269191
[TBL] [Abstract][Full Text] [Related]
3. A case of minimal change nephrotic syndrome associated with acute renal failure after excessive exercise.
Miura H; Fukui H; Hayano K; Otsuka Y; Hattori S
Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):387-91. PubMed ID: 8341018
[TBL] [Abstract][Full Text] [Related]
4. Effective improvement of minimal change nephrotic syndrome with uncontrollable high low-density lipoprotein cholesterol level using evolocumab accompanied by the development of acute pancreatitis.
Asai R; Kaneko T; Seki M; Tsuruoka S
CEN Case Rep; 2020 Nov; 9(4):333-337. PubMed ID: 32358739
[TBL] [Abstract][Full Text] [Related]
5. Minimal change disease in pregnancy.
Lo JO; Kerns E; Rueda J; Marshall NE
J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1282-4. PubMed ID: 24102437
[TBL] [Abstract][Full Text] [Related]
6. Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report.
Kim JS; Kim KJ; Choi EY
Medicine (Baltimore); 2018 Jun; 97(22):e10556. PubMed ID: 29851774
[TBL] [Abstract][Full Text] [Related]
7. Concurrent minimal change disease and retroperitoneal liposarcoma successfully treated by tumor resection and steroid therapy.
Yasui Y; Shibata R; Morita N; Himuro N; Hamauchi A; Watanabe M; Ito K; Yasuno T; Abe Y; Miyake K; Yoshimura F; Hamsaki M; Hisano S; Masutani K; Nakashima H
CEN Case Rep; 2021 Feb; 10(1):94-99. PubMed ID: 32902814
[TBL] [Abstract][Full Text] [Related]
8. Re-administration of pembrolizumab with prednisolone after pembrolizumab-induced nephrotic syndrome.
Saito S; Kadota T; Gochi M; Takagi M; Kuwano K
Eur J Cancer; 2020 Feb; 126():74-77. PubMed ID: 31923730
[No Abstract] [Full Text] [Related]
9. Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors.
Gallan AJ; Alexander E; Reid P; Kutuby F; Chang A; Henriksen KJ
Am J Kidney Dis; 2019 Dec; 74(6):853-856. PubMed ID: 31204194
[TBL] [Abstract][Full Text] [Related]
10. End-stage kidney at the onset of nephrotic syndrome in a 4-year-old girl.
Nakahata T; Tanaka H; Tsuruga K; Shimada J; Tsugawa K; Suzuki K; Onodera N; Ito E
Tohoku J Exp Med; 2003 Jul; 200(3):151-4. PubMed ID: 14521258
[TBL] [Abstract][Full Text] [Related]
11. Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case report.
Nishizono R; Kogou H; Ishizaki Y; Minakawa A; Kikuchi M; Inagaki H; Sato Y; Fujimoto S
BMC Nephrol; 2020 Sep; 21(1):410. PubMed ID: 32967631
[TBL] [Abstract][Full Text] [Related]
12. Rehabilitation of a Patient With Minimal Change Nephrotic Syndrome and Acute Kidney Injury: A Case Report.
Hirano Y; Kono K; Yamauchi K; Yasuda H
J UOEH; 2022; 44(3):257-262. PubMed ID: 36089343
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous improvement of minimal-change nephrotic syndrome and anemia with steroid therapy.
Yabana M; Kihara M; Toya Y; Tamura K; Matsumoto K; Takagi N; Kamijo S; Ishii M; Umemura S
Nephron; 1999 Jan; 81(1):84-8. PubMed ID: 9884426
[TBL] [Abstract][Full Text] [Related]
14. Nephrotic syndrome with acute kidney injury due to combination therapy of immune checkpoint inhibitors: a case report and review of the literature.
Saiki R; Katayama K; Saiki H; Fukumori A; Tsujimoto K; Yamawaki M; Tanaka F; Takahashi D; Oda K; Suzuki Y; Murata T; Dohi K
BMC Nephrol; 2024 Feb; 25(1):51. PubMed ID: 38336610
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome.
Nishide K; Nakatani S; Mori K; Morioka F; Machiba Y; Uedono H; Tsuda A; Inaba M; Ishimura E; Emoto M
Clin Exp Nephrol; 2021 Mar; 25(3):261-269. PubMed ID: 33247826
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
17. [Cerebral venous thrombosis in minimal change nephrotic syndrome].
Hirata M; Kuroda M; Koni I
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):464-8. PubMed ID: 10441998
[TBL] [Abstract][Full Text] [Related]
18. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report.
Kwon O; Kim Y; Paek JH; Park WY; Han S; Sin H; Jin K
Medicine (Baltimore); 2022 Mar; 101(10):e28997. PubMed ID: 35451393
[TBL] [Abstract][Full Text] [Related]
19. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy.
Nishi K; Sato M; Ogura M; Okutsu M; Ishikura K; Kamei K
BMC Nephrol; 2020 Aug; 21(1):323. PubMed ID: 32746791
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury complicating nephrotic syndrome of minimal change disease.
Meyrier A; Niaudet P
Kidney Int; 2018 Nov; 94(5):861-869. PubMed ID: 29980292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
